# Xeomin

NDC: 46783-161
Generic name: incobotulinumtoxinA
Labeler / Manufacturer: Merz North America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20110801

FDA application: BLA125360

## Active ingredients

- BOTULINUM TOXIN TYPE A: 50 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46783-161"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46783-161
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3f35d6e0-3450-4abc-a0da-cc7b277e7c6e